Filtern
Erscheinungsjahr
- 2016 (4) (entfernen)
Dokumenttyp
- Vortrag (2)
- Posterpräsentation (2)
Referierte Publikation
- nein (4) (entfernen)
Schlagworte
- SAXS (3)
- Silver (2)
- Albumin (1)
- Biological application (1)
- Ligand exchange (1)
- Nanoparticle (1)
- Nanoparticles (1)
- Small-angle X-ray scattering (1)
- Toxicity (1)
Eingeladener Vortrag
- nein (2)
We report on the development of ultra-small core-shell silver nanoparticles synthesized by an up-scaled modification of the polyol process. It is foreseen to use these thoroughly characterized particles as reference material to compare the catalytic and biological properties of functionalized silver nanoparticles. Small-angle X-ray scattering (SAXS) analysis reveal a narrow size distribution of the silver cores with a mean radius of RC = 3.0 nm and a distribution width of 0.6 nm. Dynamic light scattering (DLS) provides a hydrodynamic radius of RH = 10.0 nm and a PDI of 0.09. The particles’ surface is covered with poly(acrylic acid) (PAA) forming a shell with a thickness of 7.0 nm, which provides colloidal stability lasting for more than six months at ambient conditions. The PAA can be easily exchanged by biomolecules to modify the surface functionality. Replacements of PAA with glutathione (GSH) and bovine serum albumin (BSA) have been performed as examples. We demonstrate that the particles effectively catalyze the reduction of 4-nitrophenol to 4-aminophenol with sodium borohydride. The tunable catalytic activity of (436 ± 24) L g-1 s-1 is the highest reported in literature for silver nanoparticles.
Tracking silver nanoparticles: ultra-small silver refunctionalizable with fluorescent biopolymers
(2016)
We report on the synthesis of ultra-small silver nanoparticles and their quantitative characterization by small-angle X-ray scattering. The size distribution was derived by utilizing a Monte-Carlo data evaluation procedure reported by Pauw et al. Mean volume-weighted sizes are 3 nm with a size distribution width of 18 %. The particles should be used as reference materials for comparison of the result of different analytical methods among which are field-flow fractionation (FFF), dynamic light scattering (DLS), nanoparticle tracking analysis (NTA) and electron microscopy (EM). In addition further use of the particles is foreseen for comparison of studies on the toxicology of nanoparticles. Therefore the silver nanoparticles are transfunctionalized with fluorescent marked albumin (BSA-FITC) and also thoroughly characterized. With this it is possible to track silver nanoparticles and their behavior in interaction with cells.
Characterization of silver nanoparticles in cell culture medium containing fetal bovine serum
(2016)
Nanoparticles are being increasingly used in consumer products worldwide, and their toxicological effects are currently being intensely debated. In vitro tests play a significant role in nanoparticle risk assessment, but reliable particle characterization in the cell culture medium with added fetal bovine serum (CCM) used in these tests is not available. As a step toward filling this gap, we report on silver ion release by silver nanoparticles, and changes in the particle radii and in their protein corona when incubated in CCM. Particles of a certified reference material (CRM), p1, and particles of a commercial silver nanoparticle material, p2, were investigated. The colloidal stability of p1 is provided by the surfactants polyethylene glycole-25 glyceryl trioleate and polyethylene glycole-20 sorbitan monolaurate, whereas p2 is stabilized by polyvinylpyrrolidone (PVP). Dialysis of p1 and p2 reveal that their silver ion release rates in CCM are much larger than in water. Particle characterization was performed with asymmetrical flow field-flow fractionation (FFF), small-angle X-ray scattering (SAXS), dynamic light scattering (DLS) and electron microscopy. p1 and p2 have similar hydrodynamic radii of 15 nm and 16 nm, respectively. The silver core radii are 9.2 and 10.2 nm. Gel electrophoresis and subsequent peptide identification reveal that albumin is the main corona component of p1 and p2 after incubation in CCM, which consists of Dulbeccos Modified Eagle Medium with 10% fetal bovine serum added.